Can CMS put cannabinoids into Medicare for reimbursement without FDA approval, without safety analysis, and without public rule making?" stated Duane Boise, CEO MMJ International Holdings. WASHINGTON, ...
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory ...
MEDP Class Action: Medpace Sued for Securities Fraud After Cancellation Rates Lead to 16% Stock Drop
Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...
PharmaNest, a leader in high-resolution single-fiber digital pathology and AI, will present five communications at Digestive Disease Week (DDW) 2026, showcasing its advanced technologies for the study ...
"The Senior Care Influencer" joins forces with the free AI platform bringing caregivers immediate support, guidance, and hope. PHOENIX, AZ / ACCESS Newswire / April 24, 2026 / CaregiverCompanion.ai, ...
Dr. Martin explains the role of biological age, NAD levels, and advanced diagnostics in guiding long-term health strategies. MIAMI BEACH, FL / ACCESS Newswire / April 24, 2026 / Dr. Alonso Martin, ...
Iridius, a compliance-by-design AI platform for regulated workflow execution, today announced it has raised $8.6 million in seed funding led by Chalfen Ventures, with participation from Osage Venture ...
Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of ...
Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...
All Eyes on DME’ campaign aims to educate and empower people impacted by or at-risk for diabetic macular edema (DME)—a ...
If confirmed by the European Commission, REDEMPLO would be the first and only siRNA medicine authorized in the EU for both genetically confirmed and clinically diagnosed adult patients with FCS– ...
Paying Patients to Access the Nation’s #1 Prescribed Oral Blood ThinnerPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #Eliquis--The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY) — (Pfizer NYSE: PFE) Alliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results